Conference Proceedings

Final Results of a Phase 1b 28-Day Study of ABI-H0731, a Novel Core Inhibitor, in Non-Cirrhotic Viremic Subjects with Chronic Hepatitis B

Man-Fung Yuen, Kosh Agarwal, Edward J Gane, Christian Schwabe, Sang Hoon Ahn, Dong Joon Kim, Young-Suk Lim, Wendy Cheng, William Sievert, Kumar Visvanathan, Eric Ruby, Sandy Liaw, Ran Yan, Emily Connelly, Dawei Cai, Qi Huang, Richard Colonno, Uri A Lopatin

HEPATOLOGY | WILEY | Published : 2018


Funding Acknowledgements

Man-Fung Yuen - Abbvie: Advisory Committee or Review Panel; Arrowhead: Grant/Research Support; Bristol Myers Squibb: Grant/Research Support; Gilead: Advisory Committee or Review Panel; Fujerubio: Speaking and Teaching; Roche: Advisory Committee or Review Panel; MSD: Advisory Committee or Review PanelKosh Agarwal - abbvie: Advisory Committee or Review Panel; abbvie: Grant/Research Support; gilead: Consulting; gilead: Grant/Research Support; gilead: Speaking and Teaching; merck: Speaking and Teaching; merck: Grant/Research Support; vir: Consulting; arbutus: Consulting; merck: ConsultingKumar Visvanathan - Qiagen: Advisory Committee or Review Panel; Gilead: Grant/Research Support; Abbvie: Grant/Research Support